Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
NextCure, Inc. (NXTC) had Stock-Based Compensation of $2.55M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-8.62M |
|
-- |
|
-- |
|
$8.95M |
|
$-8.95M |
|
$0.32M |
|
$-8.62M |
|
$-8.62M |
|
$-8.62M |
|
$-8.62M |
|
$-8.62M |
|
$-8.62M |
|
$-8.95M |
|
$-8.46M |
|
2.68M |
|
2.68M |
|
$-3.22 |
|
$-3.22 |
|
| Balance Sheet Financials | |
$32.64M |
|
$3.64M |
|
$6.97M |
|
$39.61M |
|
$10.99M |
|
-- |
|
$4.97M |
|
$15.97M |
|
$23.65M |
|
$23.65M |
|
$23.65M |
|
2.68M |
|
| Cash Flow Statement Financials | |
$-41.98M |
|
$19.55M |
|
$2.02M |
|
$27.73M |
|
$7.32M |
|
$-20.40M |
|
|
Stock-Based Compensation |
$2.55M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.97 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-41.98M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-36.47% |
|
-36.47% |
|
-21.77% |
|
-36.47% |
|
$8.84 |
|
$-15.69 |
|
$-15.69 |
|